STOCK TITAN

Pro-Dex insider Cabillot receives 1,000 restricted PDEX shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Pro-Dex, Inc. (PDEX) reported an insider equity award for director and 10% owner Raymond E. Cabillot. On 11/20/2025 he acquired 1,000 shares of common stock at a price of $0.00, described as a grant of restricted shares under the company’s 2016 Equity Incentive Plan.

Following this grant, he beneficially owns 2,000 common shares directly and 270,846 common shares indirectly through Farnam Street Partners, L.P. This filing is a standard Form 4 disclosure of insider ownership and compensation in stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CABILLOT RAYMOND E

(Last) (First) (Middle)
3033 EXCELSIOR BLVD. STE 560

(Street)
MINNEAPOLIS MN 55416

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PRO DEX INC [ PDEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/20/2025 A(1) 1,000 A $0.00 2,000 D
Common Stock 270,846 I By Farnam Street Partners, L.P.
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Grant of restricted shares under the Issuer's 2016 Equity Incentive Plan.
/s/ Alisha Charlton as attorney-in-fact for Raymond E. Cabillot 11/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Pro-Dex (PDEX) report in this Form 4?

The Form 4 reports that Raymond E. Cabillot, a director and 10% owner of Pro-Dex, acquired 1,000 shares of common stock on 11/20/2025.

What was the price and nature of the Pro-Dex (PDEX) shares acquired?

The insider received 1,000 common shares at a price of $0.00 per share as a grant of restricted shares under the 2016 Equity Incentive Plan.

How many Pro-Dex (PDEX) shares does the insider own after this transaction?

After the transaction, the reporting person holds 2,000 common shares directly and 270,846 common shares indirectly through Farnam Street Partners, L.P.

What is the relationship of the reporting person to Pro-Dex (PDEX)?

The reporting person is both a Director of Pro-Dex and a 10% Owner of the company.

Under which plan were the Pro-Dex (PDEX) restricted shares granted?

The 1,000 restricted shares were granted under Pro-Dex’s 2016 Equity Incentive Plan.

Is this Pro-Dex (PDEX) Form 4 filing for one or multiple reporting persons?

The filing is indicated as a Form filed by one reporting person, covering the holdings of the single insider named.

Pro-Dex Inc Colo

NASDAQ:PDEX

PDEX Rankings

PDEX Latest News

PDEX Latest SEC Filings

PDEX Stock Data

141.15M
2.09M
35.94%
32.91%
7.98%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
IRVINE